论文部分内容阅读
一项新的测试展现出诱人的前景,它是基于乳腺癌细胞雌激素受体的活性而不是其数量,以便准确地预测哪些乳腺癌患者可以从激素治疗中获益。 多数乳腺癌受到雌激素刺激,因此
A new test shows an attractive prospect based on the activity of breast cancer cells rather than the amount of estrogen receptors in order to accurately predict which breast cancer patients can benefit from hormone therapy. Most breast cancer is estrogen-stimulated, therefore